In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
484 News Items found
Image of dividing breast cancer cells taken with electron microscope.
In the Lab
Researchers Identify Why Women May Develop Resistance to a New Class of Breast Cancer Drugs

Clues emerge about why promising new breast cancer drugs sometimes don’t work — and what might be done about it.
Radiologist Maxine Jochelson
Finding
Imaging and Artificial Intelligence Tools Help Predict Response to Breast Cancer Therapy

For HER2-positive breast cancers, MRI scans that employ machine-learning algorithms can provide more guidance than biopsies alone.
Boris Mueller, MD, Director, Radiation Oncology at MSK Bergen is seen standing in a hallway.
Breast Cancer and Tattoo-Less Radiation at MSK

Learn how people with early stage breast cancer can receive radiation therapy without the need for tattoos at Memorial Sloan Kettering Cancer Center.
Rachel Samuels Rand (l) with her husband, Brendan Rand.
3-D Nipple Tattoos After Breast Cancer Surgery: An MSK Specialty

Learn how specialists at Memorial Sloan Kettering tattoo highly realistic nipples and areolas on people who have had them removed during surgery for breast cancer.
Man meets with a doctor
In the News
FDA Recommends Including Men in Breast Cancer Trials

The recommendation comes in the form of draft guidelines open for public comment until October 2019.
Memorial Sloan Kettering Ralph Lauren Center nurse Jasmine Gibson, breast cancer patient Maria Tucker, and nurse Margaret Bediones
Expert Breast Cancer Treatment in Harlem at MSK’s Ralph Lauren Center

See how experts at Memorial Sloan Kettering Cancer Center's Ralph Lauren Center cared for Maria close to home.
Kate Delp standing on the beach, smiling and holding a yoga mat
Finding
Why More People With Breast Cancer Are Choosing Lumpectomy Over Mastectomy: Kate’s Story

An MSK study found a rise in lumpectomies and a decline in mastectomies — reversing a trend that experts say was leading to the overtreatment of breast cancer.
Head shot of doctor with glasses, white shirt, and blue tie in his lab.
In the Clinic
Drug Reduces Recurrence Risk in Subset of Women with Breast Cancer

A drug was shown to improve outcomes in women with HER2-positive early breast cancer when added to standard therapy.
Shanu Modi
In the Clinic
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)

On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist Shanu Modi.
Reilly Starr with her husband and their son on her husband's shoulders
Always by Your Side: How MSK Helps People Facing Metastatic Breast Cancer

Learn how people facing metastatic breast cancer help each other in support groups at Memorial Sloan Kettering.